Abnormal uterine bleeding cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Arooj Naz, M.B.B.S

Overview

Women are subjected to increased financial burden to treat underlying abnormal uterine bleeding. Annually, they loose USD $2,000.00 on account of work absences. Hormonal medications range from USD $172.00 for contraceptive pills, USD $930.00 for levonorgestrel IUD and upwards of USD $30,000.00 for hysterectomies.

Cost-effectiveness of Therapy

Cost related to the treatment of abnormal uterine bleeding depends on the underlying cause. Studies show that women in the United States have lost more than USD $2,000.00 annually due cyclical pain and resultant work absences. The annual cost of fibroids was calculated to be USD $4.1-$9.4 billion.^[1]

Treatment Costs for Dysfunctional Uterine Bleeding
Treatment modality	Cost-effectiveness
Contraceptive Pill^[2]	USD $172.00
Levonorgestrel IUD^[3]	USD $930.00; Copper-T IUD is a cheaper IUD but would exacerbate vaginal bleeding and is not recommended (USD $647.00)
Abdominal Hysterectomy^[4]	USD $43,622.00; costs vary depending on operative time, and length of stay
Vaginal Hysterectomy^[4]	USD $31,934.00; costs vary depending on operative time, and length of stay
Laparoscopic Hysterectomy^[4]	USD $38,312.00; costs vary depending on operative time, and length of stay
Robotic Hysterectomy^[4]	USD $49,526.00; costs vary depending on operative time, and length of stay

References

↑ Whitaker L, Critchley HO (2016). “Abnormal uterine bleeding”. Best Pract Res Clin Obstet Gynaecol. 34 ( ): 54–65. doi:10.1016/j.bpobgyn.2015.11.012. PMC 4970656. PMID 26803558.
↑ Torres A, Forrest JD (1983). “The costs of contraception”. Fam Plann Perspect. 15 (2): 70–2. PMID 6671479.
↑ Trussell J, Lalla AM, Doan QV, Reyes E, Pinto L, Gricar J (2009). “Cost effectiveness of contraceptives in the United States”. Contraception. 79 (1): 5–14. doi:10.1016/j.contraception.2008.08.003. PMC 3638200. PMID 19041435.
↑ ^4.0 ^4.1 ^4.2 ^4.3 Wright KN, Jonsdottir GM, Jorgensen S, Shah N, Einarsson JI (2012). “Costs and outcomes of abdominal, vaginal, laparoscopic and robotic hysterectomies”. JSLS. 16 (4): 519–24. doi:10.4293/108680812X13462882736736. PMC 3558885. PMID 23484557.

Template:WH Template:WS

[pmid26803558-1] Whitaker L, Critchley HO (2016). “Abnormal uterine bleeding”. Best Pract Res Clin Obstet Gynaecol. 34 ( ): 54–65. doi:10.1016/j.bpobgyn.2015.11.012. PMC 4970656. PMID 26803558.

[pmid66714792-2] Torres A, Forrest JD (1983). “The costs of contraception”. Fam Plann Perspect. 15 (2): 70–2. PMID 6671479.

[pmid19041435-3] Trussell J, Lalla AM, Doan QV, Reyes E, Pinto L, Gricar J (2009). “Cost effectiveness of contraceptives in the United States”. Contraception. 79 (1): 5–14. doi:10.1016/j.contraception.2008.08.003. PMC 3638200. PMID 19041435.

[pmid23484557-4] 4.0 ^4.1 ^4.2 ^4.3 Wright KN, Jonsdottir GM, Jorgensen S, Shah N, Einarsson JI (2012). “Costs and outcomes of abdominal, vaginal, laparoscopic and robotic hysterectomies”. JSLS. 16 (4): 519–24. doi:10.4293/108680812X13462882736736. PMC 3558885. PMID 23484557.

[1]

[2]

[3]

[4]